SCHEMBL901466

SCHEMBL901466

O=C(O)C1C[C@H](F)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305909 1.00
SCHEMBL6196827 1.00
SCHEMBL901476 1.00
SCHEMBL187962 1.00
SCHEMBL900297 1.00
SCHEMBL661917 1.00
SCHEMBL16635328 1.00
SCHEMBL187963 1.00
Hydrochloric Acid SCHEMBL6201099 0.98 CYP2D6 (0.56)
Hydrochloric Acid SCHEMBL21598085 0.98 CYP2D6 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122521-B2 COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2006-10-17 US claimed
WO-2005000872-A2 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-01-06 WO claimed
US-20050004032-A1 Collagen mimics NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-01-06 US claimed
EP-1007568-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2000-06-14 EP claimed
US-5973112-A Collagen mimics WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-10-26 US claimed
WO-1999010381-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-03-04 WO claimed
EP-2945952-B1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2019-08-28 EP disclosed
US-20190002480-A1 Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases MERCK SHARP & DOHME CORP. (US) 2019-01-03 US disclosed
EP-2621279-B1 FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2018-04-04 EP disclosed
US-9555038-B2 Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-01-31 US disclosed
US-9504690-B2 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2016-11-29 US disclosed
EP-2685984-B1 TETRACYCLIC XANTHENE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2016-11-02 EP disclosed
US-20160257697-A1 THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OFUSE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2016-09-08 US disclosed
EP-1007568-B1 COLLAGEN MIMICS WISCONSIN ALUMNI RES FOUND (US) 2007-08-29 EP disclosed
US-7122521-B2 COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2006-10-17 US disclosed
WO-2005000872-A2 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-01-06 WO disclosed
US-20050004032-A1 Collagen mimics NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-01-06 US disclosed
EP-1007568-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2000-06-14 EP disclosed
US-5973112-A Collagen mimics WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-10-26 US disclosed
WO-1999010381-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-03-04 WO disclosed